Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five ...

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

Sharon decided to start losing weight after looking back at her ruined metabolism and wanting the chance to spend time with ...

A MOTHER who put her daughter on weight loss jabs at the age of 11 has opened up on her family’s experience with the ...

I have lost 3st (19kg) in six months with Mounjaro injections, but I've noticed my hair is getting much thinner. Is there ...

Semaglutide has surged in popularity over the past two years, thanks to its remarkable effectiveness as a long-acting GLP-1 ...

A PHARMACY worker who stole weight loss drug Ozempic and sold it on the black market was spared jail yesterday. Akshay Sennik ...

Healthcare professionals are calling for a fundamental shift in public perception around medically supervised weight loss ...

India is emerging as a key player in the global weight management industry, driven by a rising obesity crisis and the impending patent expirations of blockbuster drugs. Pharmaceutical giants are ...

DR NELLY KAMWALEKenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 diabetes and obesity. Two drugs, Semaglutide and Tirzepatide ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

At the intersection of aesthetics and science, RegenCen is changing how patients think about aging. Born from a fusion of ...